✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Tyche Industries Ltd.

TYCHE

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹138 Cr.
P/E
11.42

Tyche Industries Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
138 Cr
PE
PE
11.42
Prom Holding
Prom Holding
61.97 %
ROE (%)
ROE (%)
9.66
ROCE (%)
ROCE (%)
12.77
Div Yield (%)
Div Yield (%)
1.85
Sales
Sales
63.35 Cr
OPM (%)
OPM (%)
17.88 %
Debt to Equity
Debt to Equity
-
View more
Edit Ratio's
About
Tyche Industries Ltd, initially a software company, diversified into the production of fine ch… Read more
Low
129
52W Range
High
225
  • Tyche Inds
  • Smruthi Organics
  • Bal Pharma

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates
Custom financial statementNew
Edit rows
Forensics

6 Yes

Positive for this company

2 Neutral

Neutral for this company

9 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operational Metrics

    locked
    Select a Metric
    • Advertisement Spend as a % of Total Sales (%)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    FAQs on Tyche Industries Ltd. Business

    Tyche Industries Ltd started as a software company and later expanded into manufacturing fine chemicals. They specialize in API's, Intermediates, Nutraceuticals, Fine and Specialty Chemicals through Custom Synthesis/Contract/Toll Manufacturing and Research & Development.

    Tyche Inds major competitors are Smruthi Organics, Bal Pharma, Mangalam Drugs&Org., Lasa Supergenerics, Nectar Lifesciences, SMS Lifesciences, Everest Organics.
    Market Cap of Tyche Inds is ₹138 Crs.
    While the median market cap of its peers are ₹141 Crs.

    Tyche Inds seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    View FAQ's On Shareprice
    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Jun
    Investor Presentation
    Conference Call
    Conference Call SummaryCon Call Summary
    Discussions & Analysis
    Tyche Industries Ltd.
    View the discussion on ValuePickr
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material